SYN

Synthetic Biologics (SYN)

Synthetic Biologics Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:SYN

<< Previous 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Next >>

Date	Time	Source	Headline	Symbol	Company
02/22/2013	7:00AM	PR Newswire (US)	Synthetic Biologics Reports that Flupirtine Sublicensee, Meda AB, to Initiate Phase II Fibromyalgia Clinical Trial in U.S.	AMEX:SYN	Synthetic Biologics Inc
02/12/2013	5:01PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	AMEX:SYN	Synthetic Biologics Inc
02/12/2013	4:58PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	AMEX:SYN	Synthetic Biologics Inc
02/11/2013	3:29PM	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:SYN	Synthetic Biologics Inc
02/05/2013	7:00AM	PR Newswire (US)	Synthetic Biologics to Present at the 2013 BIO CEO & Investor Conference	AMEX:SYN	Synthetic Biologics Inc
01/18/2013	9:36AM	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	AMEX:SYN	Synthetic Biologics Inc
01/08/2013	5:27PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	AMEX:SYN	Synthetic Biologics Inc
01/08/2013	5:27PM	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	AMEX:SYN	Synthetic Biologics Inc
01/08/2013	5:18PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	AMEX:SYN	Synthetic Biologics Inc
01/08/2013	5:18PM	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	AMEX:SYN	Synthetic Biologics Inc
01/08/2013	2:15PM	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:SYN	Synthetic Biologics Inc
01/08/2013	2:15PM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:SYN	Synthetic Biologics Inc
01/07/2013	4:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:SYN	Synthetic Biologics Inc
01/07/2013	4:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:SYN	Synthetic Biologics Inc
01/07/2013	7:00AM	PR Newswire (US)	Synthetic Biologics to Present at OneMedForum San Francisco 2013	AMEX:SYN	Synthetic Biologics Inc
01/04/2013	4:31PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:SYN	Synthetic Biologics Inc
01/04/2013	4:31PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:SYN	Synthetic Biologics Inc
01/03/2013	4:48PM	Edgar (US Regulatory)	Certified Annual Shareholder Report for Management Investment Companies (n-csr)	AMEX:SYN	Synthetic Biologics Inc
01/03/2013	4:48PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:SYN	Synthetic Biologics Inc
01/03/2013	4:48PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:SYN	Synthetic Biologics Inc
12/21/2012	10:03AM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	AMEX:SYN	Synthetic Biologics Inc
12/21/2012	10:03AM	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	AMEX:SYN	Synthetic Biologics Inc
12/21/2012	9:01AM	Edgar (US Regulatory)	Registration of Securities by Certain Investment Companies. Declaration of Election Rule 24f-2 Notice (24f-2nt)	AMEX:SYN	Synthetic Biologics Inc
12/21/2012	9:01AM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	AMEX:SYN	Synthetic Biologics Inc
12/21/2012	9:01AM	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	AMEX:SYN	Synthetic Biologics Inc
12/21/2012	6:04AM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:SYN	Synthetic Biologics Inc
12/21/2012	6:04AM	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:SYN	Synthetic Biologics Inc
12/21/2012	6:01AM	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	AMEX:SYN	Synthetic Biologics Inc
12/21/2012	6:01AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	AMEX:SYN	Synthetic Biologics Inc
12/20/2012	4:00PM	PR Newswire (US)	Synthetic Biologics and Intrexon Corporation Initiate Development of Monoclonal Antibodies for Whooping Cough (Pertussis)	AMEX:SYN	Synthetic Biologics Inc